(Q59139683)

https://api.crossref.org/works/10.1177%2F107602969500100208

Haemorrhagic complications of heparin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Heparin therapy: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Occlusive impedance phlebography: a diagnostic procedure for venous thrombosis and pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Combined use of leg scanning and impedance plethysmography in suspected venous thrombosis. An alternative to venography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Heparin and the in-hospital management of deep venous thrombosis: cost considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Low-molecular-weight heparin: is small beautiful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-Novo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Iatrogenic illness on a general medical service at a university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

The Nature of Adverse Events in Hospitalized Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Diagnosis of deep-vein thrombosis using duplex ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Is embolic risk conditioned by location of deep venous thrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Impedance plethysmography: the relationship between venous filling and sensitivity and specificity for proximal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

The angiographic differential diagnosis of acute pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

The box plot: a simple visual method to interpret data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208

Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602969500100208